Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02990572 · ClinicalTrials.gov registry record
Amish/Mennonite Research Contact Registry
A clinical trial of ALL, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT02990572 is a study of ALL that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 1,000 participants, above the 884-participant average among 13 other ALL trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02990572, a study of ALL, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this registry is to find members of the Plain Community who are interested in participating in future medical research studies. Having a registry makes it easier to contact and offer study participation to individuals who are appropriate for a new research study based on their own and their family medical history. Studies will focus on increasing knowledge about disorders affecting those who are Amish and Mennonite.
Conditions Studied
Study Locations (1)
Pennsylvania
- Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-10 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02990572
The ClinicalTrials.gov registry entry for NCT02990572 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 884-participant average among 13 other ALL trials with a reported enrollment target (13% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ALL appearing as the primary indexed condition, and to 0 interventions.
NCT02990572 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02990572 about?
NCT02990572 is a clinical study titled "Amish/Mennonite Research Contact Registry". The purpose of this registry is to find members of the Plain Community who are interested in participating in future medical research studies. Having a registry makes it easier to contact and offer study participation to individuals who are appropriate for a new research study based on their own and...
What is the current status of trial NCT02990572?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-10. Estimated completion is 2030-12.
What conditions does trial NCT02990572 study?
This clinical trial studies the following conditions: ALL.
Who is sponsoring clinical trial NCT02990572?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02990572 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
RECRUITING · Phase 1
-
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RECRUITING · Phase 1
-
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RECRUITING
-
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
RECRUITING · Phase 2
-
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
RECRUITING · Phase 1
-
A Long Term Follow-up Study of TScan TCR-T Products
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.